Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Hadi Samadi

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Nuclear Medicine|July 7, 2026
Fibrous Dysplasia With 99m Tc-FAPI Uptake in a Patient Under Long-term Antiresorptive TherapyMohammad Hadi Samadi, Pegah Sahafi, Ali Emadi Toghabeh, et al.
Clinical Nuclear Medicine|February 21, 2025
Radio-Guided Monitoring of Systemic Leakage With 99m Tc-MAA Uptake in a Patient With Melanoma During Isolated Limb PerfusionMohammad Hadi Samadi, Ehsan Hasanzadeh Hadad, Susan Khezri, et al.
The Archives of Bone and Joint Surgery|June 5, 2026
Imaging Atlas of Osseous Pathology in the Ankle and FootPegah Sahafi, Mohammad Hadi Samadi, Alireza Mousavian, et al.
Clinical Nuclear Medicine|June 5, 2026
Sudden Diffuse Hepatic Metastases After First 177Lu-PSMA Cycle in Bone Predominant mCRPC PatientMohammad Hadi Samadi, Saeed Forouzanian, Pegah Sahafi, et al.
Clinical Nuclear Medicine|May 20, 2025
A Rare Case of Osteoid Osteoma of the Distal Physis of the Fibula Confirmed by Bone SPECT/CT ScanningMohammad Hadi Samadi, Susan Khezri, Salman Soltani, et al.
Clinical Nuclear Medicine|May 11, 2026
Response Assessment of Gastric Adenocarcinoma Using ⁶⁸Ga-FAPI-46 and 18F-FDG PET/CT: Highlighting the Role of the Tumor Microenvironment in Therapy ResistanceMahsa Sheikhnezami, Mohammad Hadi Samadi, Ramin Sadeghi, et al.
Clinical Genitourinary Cancer|January 31, 2026
Treatment Discontinuation in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Lutetium-177 (<sup>177</sup>Lu)-PSMA-617: A Retrospective Real-World StudyMohammad Hadi Samadi, Amirreza Shamshirgaran, Pegah Sahafi, et al.
Clinical Nuclear Medicine|November 27, 2025
99mTc- FAPI Uptake in Immunoglobulin G4-Related Orbital and Sinonasal Disease With Bone InvolvementZahra Mirfeizi, Mohammad Hadi Samadi, Elham Atabati, et al.
BMC Cancer|May 29, 2026
[¹⁷⁷Lu]Lu-FAPI-2286 radioligand therapy in heavily pre-treated patients with advanced breast and gastrointestinal cancers: a single-center retrospective experienceFaeze Rabani, Mohammad Hadi Samadi, Sajjad Sadeghpour, et al.
Annals of Nuclear Medicine|November 7, 2025
Efficacy and safety of Lutetium-177 (<sup>177</sup>Lu)-PSMA-617 in metastatic Castration-Resistant prostate cancer patients with superscan pattern: A retrospective cohort studyAmirreza Shamshirgaran, Pegah Sahafi, Mohammad Hadi Samadi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Nuclear Medicine|July 7, 2026
Fibrous Dysplasia With 99m Tc-FAPI Uptake in a Patient Under Long-term Antiresorptive TherapyMohammad Hadi Samadi, Pegah Sahafi, Ali Emadi Toghabeh, et al.
Clinical Nuclear Medicine|February 21, 2025
Radio-Guided Monitoring of Systemic Leakage With 99m Tc-MAA Uptake in a Patient With Melanoma During Isolated Limb PerfusionMohammad Hadi Samadi, Ehsan Hasanzadeh Hadad, Susan Khezri, et al.
The Archives of Bone and Joint Surgery|June 5, 2026
Imaging Atlas of Osseous Pathology in the Ankle and FootPegah Sahafi, Mohammad Hadi Samadi, Alireza Mousavian, et al.
Clinical Nuclear Medicine|June 5, 2026
Sudden Diffuse Hepatic Metastases After First 177Lu-PSMA Cycle in Bone Predominant mCRPC PatientMohammad Hadi Samadi, Saeed Forouzanian, Pegah Sahafi, et al.
Clinical Nuclear Medicine|May 20, 2025
A Rare Case of Osteoid Osteoma of the Distal Physis of the Fibula Confirmed by Bone SPECT/CT ScanningMohammad Hadi Samadi, Susan Khezri, Salman Soltani, et al.
Clinical Nuclear Medicine|May 11, 2026
Response Assessment of Gastric Adenocarcinoma Using ⁶⁸Ga-FAPI-46 and 18F-FDG PET/CT: Highlighting the Role of the Tumor Microenvironment in Therapy ResistanceMahsa Sheikhnezami, Mohammad Hadi Samadi, Ramin Sadeghi, et al.
Clinical Genitourinary Cancer|January 31, 2026
Treatment Discontinuation in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Lutetium-177 (<sup>177</sup>Lu)-PSMA-617: A Retrospective Real-World StudyMohammad Hadi Samadi, Amirreza Shamshirgaran, Pegah Sahafi, et al.
Clinical Nuclear Medicine|November 27, 2025
99mTc- FAPI Uptake in Immunoglobulin G4-Related Orbital and Sinonasal Disease With Bone InvolvementZahra Mirfeizi, Mohammad Hadi Samadi, Elham Atabati, et al.
BMC Cancer|May 29, 2026
[¹⁷⁷Lu]Lu-FAPI-2286 radioligand therapy in heavily pre-treated patients with advanced breast and gastrointestinal cancers: a single-center retrospective experienceFaeze Rabani, Mohammad Hadi Samadi, Sajjad Sadeghpour, et al.
Annals of Nuclear Medicine|November 7, 2025
Efficacy and safety of Lutetium-177 (<sup>177</sup>Lu)-PSMA-617 in metastatic Castration-Resistant prostate cancer patients with superscan pattern: A retrospective cohort studyAmirreza Shamshirgaran, Pegah Sahafi, Mohammad Hadi Samadi, et al.
Pageof 4